Literature DB >> 26411956

Management of Ovarian Cancer In Younger Women.

K Uma Devi, N Purushotham, N Jayashree1.   

Abstract

BACKGROUND: Ovarian Cancer is a broad spectrum of diseases comprising several subtypes. Three major categories in younger women are germ cell tumor, sex cord stromal tumor and epithelial ovarian neoplasia.
OBJECTIVE: literature search was for an update on management of ovarian cancer in young women. CONTEXT: Germ cell tumor is suspected in young girls presenting with solid ovarian neoplasm as abdominal mass, discomfort, dyspnea or pain abdomen. Preoperative evaluation should include thorough clinical examination with biochemical profile tumor markers and imaging techniques. When prepubertal girls present with precocious puberty, clitoromegaly, development of secondary sexual character, one should suspect juvenile granulosa theca cell tumor. Often serum beta inhibin is elevated in these cases. Young women are not immune to other tumors. Surgery should be fertility sparing, salphingo -oopherectomy, omentectomy, peritoneal cytology, retro peritoneal lymphadenectomy whenever indicated. Except Stage I A puredysgerminoma, Stage IA grade 1 immature teratoma, Stage IA /B grade 1 epithelial ovarian carcinoma, all other histopathological types irrespective of the stage of the disease require adjuvant chemotherapy.
CONCLUSION: Girls, young women can have ovarian cancer conservative therapy. However treatment needs to be individualized. Except stage IA disease all other patient require adjuvant chemotherapy apart from fertility sparing surgery.

Entities:  

Mesh:

Year:  2015        PMID: 26411956     DOI: 10.2174/1574887110666150923112047

Source DB:  PubMed          Journal:  Rev Recent Clin Trials        ISSN: 1574-8871


  2 in total

1.  Pyridoxine 5'-phosphate oxidase is a novel therapeutic target and regulated by the TGF-β signalling pathway in epithelial ovarian cancer.

Authors:  Lingyun Zhang; Daibing Zhou; Wencai Guan; Weimin Ren; Wenwen Sun; Jimin Shi; Qunbo Lin; Jinguo Zhang; Tiankui Qiao; Yulong Ye; Yun Wu; Yaning Zhang; Xulei Zuo; Kristin L Connor; Guoxiong Xu
Journal:  Cell Death Dis       Date:  2017-12-13       Impact factor: 8.469

2.  miR-423-5p serves as a diagnostic indicator and inhibits the proliferation and invasion of ovarian cancer.

Authors:  Xuebiao Tang; Xiaogang Zeng; Yu Huang; Shibing Chen; Fang Lin; Ge Yang; Nian Yang
Journal:  Exp Ther Med       Date:  2018-04-02       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.